Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Rivian
RIVN
$24.6B
| $4.14M | 0.11% |
+160,730
| New | +$5.02M |
|
227
Procore
PCOR
$9.65B
| $4.13M | 0.11% |
90,998
-33,072
| -27% | -$1.62M |
|
228
Crane NXT
CXT
$2.89B
| $4.12M | 0.11% |
+135,330
| New | +$4.5M |
|
229
TE Connectivity
TEL
$58.9B
| $4.1M | 0.11% |
36,261
-12,216
| -25% | -$1.51M |
|
230
Albemarle
ALB
$16.9B
| $4.09M | 0.11% |
19,587
+15,219
| +348% | +$3.4M |
|
231
Ubiquiti
UI
$33.8B
| $4.08M | 0.11% |
16,453
-7,328
| -31% | -$1.95M |
|
232
Idexx Laboratories
IDXX
$43.9B
| $4.08M | 0.11% |
+11,619
| New | +$4.74M |
|
233
Dentsply Sirona
XRAY
$2.18B
| $4.07M | 0.11% |
+113,861
| New | +$4.6M |
|
234
Amdocs
DOX
$6.41B
| $4.07M | 0.11% |
48,795
-71,682
| -59% | -$5.91M |
|
235
Freshworks
FRSH
$3.39B
| $4.06M | 0.11% |
308,486
+77,605
| +34% | +$1.21M |
|
236
Pegasystems
PEGA
$5.52B
| $4.05M | 0.11% |
169,508
+35,834
| +27% | +$1.07M |
|
237
DraftKings
DKNG
$13B
| $4.05M | 0.11% |
+346,744
| New | +$4.88M |
|
238
Revvity
RVTY
$13.9B
| $4.04M | 0.11% |
28,391
+25,152
| +777% | +$3.77M |
|
239
CNX Resources
CNX
$5.38B
| $4.03M | 0.11% |
+244,597
| New | +$5.01M |
|
240
Truist Financial
TFC
$61.6B
| $4.03M | 0.11% |
84,856
+78,813
| +1,304% | +$3.89M |
|
241
J.M. Smucker
SJM
$13.3B
| $4.01M | 0.11% |
+31,350
| New | +$4.18M |
|
242
Intuitive Surgical
ISRG
$134B
| $3.98M | 0.1% |
19,853
+11,733
| +144% | +$2.75M |
|
243
TriSalus Life Sciences
TLSI
$324M
| $3.95M | 0.1% |
401,403
| – | – |
|
|
NSA
244
DELISTED
National Storage Affiliates Trust
NSA
| $3.95M | 0.1% |
78,844
-34,421
| -30% | -$1.87M |
|
245
Winnebago Industries
WGO
$898M
| $3.94M | 0.1% |
81,164
+13,661
| +20% | +$706K |
|
246
UiPath
PATH
$8.49B
| $3.94M | 0.1% |
216,503
-2,413
| -1% | -$45.1K |
|
247
Essential Properties Realty Trust
EPRT
$6.67B
| $3.94M | 0.1% |
183,171
+126,827
| +225% | +$2.95M |
|
248
International Flavors & Fragrances
IFF
$21.5B
| $3.92M | 0.1% |
+32,888
| New | +$4.11M |
|
249
Packaging Corp of America
PKG
$22.5B
| $3.92M | 0.1% |
28,494
+23,978
| +531% | +$3.7M |
|
|
LTHM
250
DELISTED
Livent Corporation
LTHM
| $3.89M | 0.1% |
171,480
+151,215
| +746% | +$3.89M |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.